Are there any interactions between propranolol, flunarizine, and amitriptyline?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 20, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Drug Interactions Between Propranolol, Flunarizine, and Amitriptyline

These three medications can be used together safely for migraine prophylaxis, as they are commonly combined in clinical practice without significant pharmacokinetic or pharmacodynamic interactions that would preclude their concurrent use.

Evidence for Combined Use

Propranolol and Flunarizine Combination

  • Direct evidence supports the safety and efficacy of combining propranolol with flunarizine. A double-blind trial specifically evaluated propranolol 60 mg/day plus flunarizine 10 mg/day simultaneously, demonstrating that the combination was well-tolerated and showed a trend toward better efficacy than either drug alone 1.
  • The combination group achieved a migraine index of 14.4 compared to 23.4 for propranolol alone and 18.7 for flunarizine alone, with no significant safety concerns reported 1.
  • Both drugs are recognized as effective migraine prophylaxis agents, with propranolol and flunarizine listed among first-line and second-line options respectively 2.

Propranolol and Amitriptyline Combination

  • Propranolol and amitriptyline can be safely combined without clinically significant drug interactions. Research demonstrates that concurrent use of propranolol and antidepressants (including tricyclics like amitriptyline) does not attenuate therapeutic effects 3.
  • Both are recognized as first-line agents for migraine prevention, with propranolol at 80-240 mg/day and amitriptyline at 30-150 mg/day 2.
  • Guidelines note that propranolol may be superior for pure migraine, while amitriptyline is more effective for mixed migraine and tension-type headache, suggesting complementary rather than conflicting mechanisms 2.

Flunarizine and Amitriptyline Combination

  • While no specific studies directly evaluate this combination, both drugs work through different mechanisms (calcium channel blockade vs. tricyclic antidepressant effects) without known pharmacokinetic interactions 2.
  • Flunarizine is listed as a second-line agent at 5-10 mg daily, while amitriptyline remains first-line at 10-100 mg at night 2.

Important Clinical Considerations

Additive Side Effects to Monitor

  • Sedation and drowsiness: All three medications can cause tiredness. Amitriptyline causes drowsiness through anticholinergic effects 2, propranolol causes fatigue 2, and flunarizine causes tiredness 4.
  • Weight gain: Both amitriptyline and flunarizine are associated with weight gain 2, 4.
  • Depression: Propranolol can cause depression 2, and flunarizine is contraindicated in patients with depression 2.
  • Cardiovascular effects: Propranolol causes bradycardia and hypotension; monitor heart rate and blood pressure when combining with other CNS-active medications 2.

Contraindications to Consider

  • Propranolol is contraindicated in asthma, cardiac failure, Raynaud disease, and atrioventricular block 2.
  • Flunarizine is contraindicated in Parkinsonism and depression 2.
  • Amitriptyline is contraindicated in heart failure, glaucoma, and when co-administered with MAO inhibitors 2.

Dosing Strategy

  • Start with low doses and titrate slowly when combining these medications to minimize additive side effects 2.
  • Clinical benefits may not become apparent for 2-3 months, so adequate trial duration is essential 2.
  • Monitor for excessive sedation, orthostatic hypotension, and bradycardia during the titration phase 2.

Key Pitfall to Avoid

The main concern is not a dangerous drug-drug interaction but rather additive side effects, particularly sedation, weight gain, and cardiovascular effects (bradycardia, hypotension). Close monitoring during initiation and dose adjustments is essential, but these medications do not have contraindicated pharmacokinetic interactions that would prevent their combined use 3, 1.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

A comparative trial of flunarizine and propranolol in the prevention of migraine.

South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde, 1990

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.